https://wiki.tradeville.ro/index.php?action=history&feed=atom&title=Nektar_TherapeuticsNektar Therapeutics - Revizia istoricului2026-04-06T10:43:03ZIstoricul versiunilor pentru această pagină din wikiMediaWiki 1.39.2https://wiki.tradeville.ro/index.php?title=Nektar_Therapeutics&diff=432405&oldid=prevAdmin: Pagină nouă: Pagina dedicata companiei Nektar Therapeutics listata cu simbolul US.NKTR ==Descriere companie== Nektar Therapeutics (http://www.nektar.com) is a biopharmaceutical company. The Company discovers and develops medicines in areas of unmet medical need. Its research and development pipeline of new investigational drugs includes treatments for cancer and autoimmune disease. It has research and development (R&D) pipeline of medicines in oncology, immunology, and virology as well a...2024-09-18T18:16:02Z<p>Pagină nouă: Pagina dedicata companiei Nektar Therapeutics listata cu simbolul US.NKTR ==Descriere companie== Nektar Therapeutics (http://www.nektar.com) is a biopharmaceutical company. The Company discovers and develops medicines in areas of unmet medical need. Its research and development pipeline of new investigational drugs includes treatments for cancer and autoimmune disease. It has research and development (R&D) pipeline of medicines in oncology, immunology, and virology as well a...</p>
<p><b>Pagină nouă</b></p><div>Pagina dedicata companiei Nektar Therapeutics listata cu simbolul US.NKTR<br />
<br />
==Descriere companie==<br />
Nektar Therapeutics (http://www.nektar.com) is a biopharmaceutical company. The Company discovers and develops medicines in areas of unmet medical need. Its research and development pipeline of new investigational drugs includes treatments for cancer and autoimmune disease. It has research and development (R&D) pipeline of medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. It leverages its chemistry platform to discover and design new drug candidates. These drug candidates utilize its polymer conjugate technology platforms, which are designed to enable the development of new molecular entities. Its R&D pipeline includes Bempegaldesleukin (NKTR-214), NKTR-358, NKTR-262 and NKTR-255. It develops medicines designed to modulate the activity of key immune cells, such as cytotoxic T cells and Natural Killer (NK) cells, to increase their numbers and improve their function to recognize and attack cancer cells directly or indirectly.<br />
<br />
==Grafic actiuni companie==<br />
<iframe key="tradeville" path="graficSimbol/US.NKTR" /><br />
<br />
==Ultimele stiri despre Nektar Therapeutics (US.NKTR)==<br />
<dynamicpagelist><br />
category=US.NKTR<br />
count=10<br />
order=descending<br />
addfirstcategorydate=false<br />
</dynamicpagelist><br />
<br />
[[Categorie:US.NKTR]][[Categorie:Stiri despre companii]]</div>Admin